Study With AG-013736 Combined With Chemotherapy And Bevacizumab In Patients With Metastatic Colorectal Cancer - NCT00460603-47303 (Clinical Trial 168260)
Permalink: http://www.ClinicalConnection.com/exp/ExpandedPatientViewStudy168260.aspx
|
** Please review additional "Nearby Studies" on right ----->
|
|
 |
 |
|
| City: |
|
Muncie |
|
State:
|
|
IN |
| Zip Code: |
|
47303 |
| Conditions: |
|
Colorectal Neoplasms |
| Purpose: |
|
To determine the safety and efficacy of AG-013736 in combination with other standard of care
medication in patients with first line metastatic colorectal cancer.
|
| Study summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- (Phase 1) Patients with any solid/GI tumor who have had no more than 1 previous
chemotherapy for greater than 3 months prior to enrollment
- (Phase 2) Patients with locally advanced or metastatic colorectal cancer (CRC)
previously untreated with any systemic therapy.
- Patients treated with adjuvant chemotherapy (with radiation) will be eligible if last
treatment was > 12 months prior to enrollment,
- Patients must have measurable disease by RECIST and if any history of hypertension,
it must be controlled with medication.
Exclusion Criteria:
- Prior system therapy for advanced CRC (Ph 2 portion only)
- Prior treatment with anti-angiogenesis agent such as bevacizumab or VEGF inhibitors.
- Prior irradiation of greater than 25% of bone marrow (whole pelvis = 25%)
- Prior radiation, major surgery, or investigational agent within 4 weeks of study
entry except palliative radiotherapy to non-target, metastatic lesions. Minor
surgeries should be completed > 2 weeks of enrollment and be fully recovered from any
procedure. |
|
|
|
| Study is available at: |
|
Pfizer Investigational Site
Muncie, IN 47303
United States
Primary Contact:
Pfizer Oncology Clinical Trial Information Service
Email: PfizerCancerTrials@emergingmed.com
Phone: 1-877-369-9753 |
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
November 3, 2009 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Clinical trials are medical research studies designed to test the safety and/or
effectiveness of new drugs, devices, or treatments in humans. These studies are
conducted worldwide for a range of conditions and illnesses. Learn more about
clinical research and participating in a study at
About Clinical Trials.
|
|
|
|
|